60 degrees pharmaceuticals inc. announces arakoda® promotional pilot in advance of expanded u.s. launch

Highlights include increased arakoda® (tafenoquine) brand awareness and utilization through virtual sales outreach using digital behavioral analytics and a co-pay program to assist consumers with out-of-pocket costs. arakoda is the only new antimalarial in over a decade and is differentiated by a broad efficacy against all malaria stages, a convenient weekly dosing schedule, and a well-established safety profile.
SXTP Ratings Summary
SXTP Quant Ranking